Literature DB >> 9374117

Intracellular degradation of newly synthesized apolipoprotein B.

Z Yao1, K Tran, R S McLeod.   

Abstract

Intracellular degradation of newly synthesized apolipoprotein (apo) B can occur at every stage of the secretory pathway, from the protein translation, polypeptide translocation across the membrane of endoplasmic reticulum (ER), to vesicular transport. The prevalence of apoB degradation at each stage varies in different hepatic cell systems examined. Proteolysis of nascent apoB can be catalyzed by the ubiquitin-proteasome system in the cytosol, and probably by unidentified ER resident proteases as well. Cytosolic and ER lumenal molecular chaperones that facilitate apoB translocation and folding may also assist in the degradation of misfolded apoB proteins. Factors affecting the synthesis and mobilization of lipids during lipoprotein assembly exert important regulatory effects on apoB degradation in trans, and specific hydrophobic amino acid sequence elements within the apoB-100 molecule may play roles in apoB degradation in cis. This review summarizes the current understanding of the cellular and molecular mechanisms responsible for intracellular degradation of apoB in hepatocytes. The emphasis centers primarily on the topology of apoB with respect to the ER membrane during and after apoB translation and its relationship to proteolytic mechanisms potentially involved in apoB degradation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374117

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  33 in total

Review 1.  The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly.

Authors:  G F Gibbons; A M Brown; D Wiggins; R Pease
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

Review 2.  Hepatic regulation of apolipoprotein B.

Authors:  Rita Kohen Avramoglu; Khosrow Adeli
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

3.  Saccharomyces cerevisiae Ub-conjugating enzyme Ubc4 binds the proteasome in the presence of translationally damaged proteins.

Authors:  Show-Mei Chuang; Kiran Madura
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

4.  Reconstituting initial events during the assembly of apolipoprotein B-containing lipoproteins in a cell-free system.

Authors:  Z Gordon Jiang; Yuhang Liu; M Mahmood Hussain; David Atkinson; C James McKnight
Journal:  J Mol Biol       Date:  2008-09-12       Impact factor: 5.469

5.  The intracellular triacylglycerol/fatty acid cycle: a comparison of its activity in hepatocytes which secrete exclusively apolipoprotein (apo) B100 very-low-density lipoprotein (VLDL) and in those which secrete predominantly apoB48 VLDL.

Authors:  A M Salter; D Wiggins; V A Sessions; G F Gibbons
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

6.  Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone.

Authors:  Vernon W Dolinsky; Donna N Douglas; Richard Lehner; Dennis E Vance
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

7.  Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Authors:  Meenakshi Sundaram; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2010-04-27       Impact factor: 4.169

8.  Localization, function and regulation of the two intestinal fatty acid-binding protein types.

Authors:  Emile Levy; Daniel Ménard; Edgard Delvin; Alain Montoudis; Jean-François Beaulieu; Geneviève Mailhot; Nadia Dubé; Daniel Sinnett; Ernest Seidman; Moise Bendayan
Journal:  Histochem Cell Biol       Date:  2009-06-05       Impact factor: 4.304

9.  Lipid-dependent bidirectional traffic of apolipoprotein B in polarized enterocytes.

Authors:  Etienne Morel; Sylvie Demignot; Danielle Chateau; Jean Chambaz; Monique Rousset; François Delers
Journal:  Mol Biol Cell       Date:  2003-10-17       Impact factor: 4.138

10.  Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor.

Authors:  Emma M Allister; Erin E Mulvihill; P Hugh R Barrett; Jane Y Edwards; Lindsey P Carter; Murray W Huff
Journal:  J Lipid Res       Date:  2008-06-27       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.